Radiotherapy-induced Nausea and Vomiting (RINV) Clinical Trial
Official title:
Phase II Clinical Study of SyB D-0701 for Radiotherapy Induced Nausea and Vomiting
The purpose of this study is to explore the dose response of SyB D-0701 for preventing nausea and emesis associated with radiotherapy (fractionated/localized irradiation) in cancer patients scheduled to receive radiotherapy (fractionated/localized irradiation) alone.
Exploratory study of dose response of SyB D-0701 to preventing effects for nausea and emesis associated with radiotherapy (fractionated/localized irradiation) ;
Intervention Model: Parallel Assignment, Masking: Double-Blind